Ruediger Weseloh
Director/Board Member presso NYRADA INC.
Profilo
Rüdiger Weseloh's current jobs include Senior Director-Business Development at Merck KGaA, Executive Director-Business Development at EMD Serono, Inc., Independent Non-Executive Director at Nyrada, Inc., and Senior Director-Global Business Development at Merck Healthcare KGaA.
His former jobs include Equity Analyst at Gontard & Metallbank AG, Analyst at Oppenheim Research GmbH, Member-Supervisory Board at bioXXmed AG, and Head-Business Development at Merck Serono GmbH.
Dr. Weseloh's education includes a graduate degree from the University of Bayreuth and a doctorate degree from the Center For Molecular Neurobiology Hamburg.
Posizioni attive di Ruediger Weseloh
| Società | Posizione | Inizio |
|---|---|---|
| NYRADA INC. | Director/Board Member | 01/06/2019 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2006 |
| Merck Healthcare KGaA | Corporate Officer/Principal | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Ruediger Weseloh
| Società | Posizione | Fine |
|---|---|---|
| Oppenheim Research GmbH | Analyst-Equity | 03/07/2006 |
| GONTARD & METALLBANK AG | Corporate Officer/Principal | - |
Merck Serono GmbH
 Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Corporate Officer/Principal | - |
| BIOXXMED AG | Director/Board Member | - |
Formazione di Ruediger Weseloh
| University of Bayreuth | Graduate Degree |
| Center For Molecular Neurobiology Hamburg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MERCK KGAA | Health Technology |
| BIOXXMED AG | Health Technology |
| NYRADA INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Gontard & Metallbank AG
 Gontard & Metallbank AG Major BanksFinance Gontard & Metallbank AG provides banking and financial services. The company was founded by Wilhelm Merton in April 1999 and is headquartered in Frankfurt, Germany. | Finance |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Oppenheim Research GmbH | Finance |
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Health Technology |
| Merck Healthcare KGaA |
- Borsa valori
- Insiders
- Ruediger Weseloh
